4//SEC Filing
Giltner Richard 4
Accession 0001415889-24-026241
CIK 0001082554other
Filed
Nov 5, 7:00 PM ET
Accepted
Nov 6, 4:30 PM ET
Size
10.7 KB
Accession
0001415889-24-026241
Insider Transaction Report
Form 4
Giltner Richard
Director
Transactions
- Exercise/Conversion
Common Stock
2024-11-05$175.43/sh+10,000$1,754,300→ 27,420 total - Sale
Common Stock
2024-11-05$381.61/sh−8,571$3,270,749→ 18,849 total - Sale
Common Stock
2024-11-05$382.28/sh−1,429$546,273→ 17,420 total - Exercise/Conversion
Stock Options
2024-11-05−10,000→ 5,000 totalExercise: $175.43From: 2016-06-26Exp: 2025-06-26→ Common Stock (10,000 underlying)
Footnotes (2)
- [F1]This transaction was executed in multiple trades at prices ranging from $381.08 to $382.06. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
- [F2]This transaction was executed in multiple trades at prices ranging from $382.13 to $382.73. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
UNITED THERAPEUTICS Corp
CIK 0001082554
Entity typeother
Related Parties
1- filerCIK 0001460472
Filing Metadata
- Form type
- 4
- Filed
- Nov 5, 7:00 PM ET
- Accepted
- Nov 6, 4:30 PM ET
- Size
- 10.7 KB